Dilated cardiomyopathy / DCM risk panel 1-4 (PDK4/TTN/LOC102156622/RNF207) - Doberman Pinscher

What does this test examine?

This DNA test determines four genetic risk markers for dilated cardiomyopathy in the Doberman Pinscher: DCM1 in PDK4, DCM2 in TTN, DCM3 on chromosome 5 in the LOC102156622 region and DCM4 in RNF207. The condition is also known as DCM, Doberman DCM, dilated cardiomyopathy, enlarged-heart cardiomyopathy or congestive cardiomyopathy when heart failure develops.

This is deliberately a risk panel. Doberman DCM is not a simple one-gene-one-disease condition, but a complex heart disorder in which multiple genetic factors, age, family line and other influences shape the total risk. Testing several markers together gives owners and breeders more useful information than a single marker alone.

What is DCM in the Doberman?

In dilated cardiomyopathy, the heart muscle becomes weaker and especially the left ventricle, and sometimes other chambers, may enlarge. The heart pumps less effectively, which can lead to arrhythmias, reduced exercise tolerance, fainting, fluid accumulation, heart failure or sudden death. In Dobermans, DCM is an important and serious health problem that often becomes visible only in adulthood.

A genetic result does not give a simple prediction of the exact age at which signs will appear. It does show which tested risk markers are present. That information is valuable for breeding selection, mating plans and more targeted follow-up within lines where DCM occurs.

Inheritance and result

This panel is interpreted as multifactorial. For some markers, one copy already carries risk information, while other markers gain meaning especially in combination with additional genetic factors. The key question is therefore not only whether one marker is positive, but how many risk signals are present together and in which breeding or family context the dog stands.

Each subanalysis reports whether zero, one or two copies of the relevant marker class are detected. For DCM1 and DCM2, alleles are displayed as N/DCM1 and N/DCM2. For DCM3 and DCM4, nucleotide genotypes are displayed when they can be derived safely from the marker definition.

Practical value of this test

For Doberman breeders, this test is especially useful for making genetic risk load visible before a breeding decision. A dog carrying several risk markers calls for different mating choices than a dog without the tested markers. The result helps compare lines, test relatives more selectively and avoid unnecessary accumulation of risk signals.

For owners and veterinarians, the panel adds context in a breed where DCM often appears in adulthood and sometimes suddenly. The DNA result can make follow-up, family screening and breeding value discussions more concrete. Combine the result with age, family information and cardiac follow-up for the strongest decisions.

Why test?

• Combines four relevant Doberman DCM risk markers in one analysis.
• Helps breeders plan matings with less accumulation of risk markers.
• Shows which marker(s) a dog can pass to offspring.
• Supports family screening when DCM occurs in a line.
• Gives owners and veterinarians clearer genetic context for a serious breed-associated heart disorder.